RxDoctor Payments Data

Gabriel Edmondson, DO

Family Medicine · Ferrum, VANPI 1639582331

Payments from drug & device makers

$493in general payments, 2019–2025

Across 31 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$109
  • Novo Nordisk$68
  • Amarin Pharma, Inc.$63
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$42
  • AstraZeneca$36
  • Takeda Pharmaceuticals U.S.A., Inc.$34
  • plus $140 from 8 others

What the payments were for

  • Food & beverage$493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$493 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$1,522
Medicare patients
35
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$53,457
TrulicityDulaglutide26$36,186
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$17,407
JardianceEmpagliflozin17$17,093
LinzessLinaclotide11$15,669
OzempicSemaglutide11$9,594
Breo ElliptaFluticasone/Vilanterol11$9,522
Mesalamine13$7,567
Humalog Mix 75-25Insulin Lispro Protamin/Lispro11$2,580
Albuterol Sulfate HfaAlbuterol Sulfate86$2,472
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,196
LantusInsulin Glargine,hum.Rec.Anlog13$1,606
Venlafaxine Hcl ErVenlafaxine Hcl13$1,587
Atorvastatin Calcium158$1,504
Duloxetine Hcl33$1,116

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Humalog Mix 75-25$24$38,76637 claims
Boehringer IngelheimJardiance$21$17,09317 claims
AbbVieLinzess$109$15,66911 claims
Novo NordiskOzempic$68$9,59411 claims
Sanofi-aventis U.S. LLCLantus$14$1,60613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Ferrum

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →